Charles de Bock
Children's Cancer Institute, NSW, Australia
Presentations this author is a contributor to:
Targeted delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment of childhood leukaemia. (#55)
12:45 PM
Ernest Moles
Concurrent Session - Oncology Frontiers